Cell Immunotherapy for Prostate cancer is a promising new approach for treatment of cancers that otherwise did not respond well to traditional treatments, surgeries or chemotherapy. The basic goal of all immunotherapies, checkpoint inhibitors and cancer vaccines is to program the body’s own immune system to recognize and destroy only cancer cells as the enemy.
The prostate is a tubuloalveolar exocrine gland the size of a ping-pong ball (when healthy). This reproductive glands purpose is to produce and store semen. A prostate is located in front of the rectum and below the bladder around the upper urethra tube that empties urine produced by the bladder. Because of its location diseases of the prostate affect both sexual function and bladder control. Prostate diseases can be cancerous or noncancerous and can affect blood vessels and peripheral nerves that control erectile function leading to ED. Prostate cancer (PC) is a medical diagnosis with abnormal cell growth/division (malignancy) on the prostate gland. If left untreated, cancer of the prostate can spread (metastasize) to other areas in the body, including:
Metastasized prostate cancer is considered an advanced form of cancer and can even travel to the brain; however, this is very rare.
Prostate cancer is currently the #1 most common type of cancer in men (after skin cancer), and statistics show that that 1 in 9 men will be diagnosed with prostate cancer during his lifetime. Generally speaking, Prostate cancer is much more common in men over the age of 50 and is generally quite rarely diagnosed in men less than 40 years old. Prostate Cancer is currently the 2nd leading cause of cancer-related deaths in the world (behind pulmonary cancer), and it is estimated that 1 in 40 men will die from having prostate cancer.[1]
Recent Epidemiological studies have shown that some distinct geographical and racial distribution for men with prostate cancer and that this disease is more prevalent in Western societies than Asian ones such as Thailand where prostate cancer is the 6th leading type of cancer.[2] The highest rates of prostate cancers were found in Western and Northern European nations such as France, Norway and also in New Zealand, Australia, and North America.
Early intervention and detection is the key to dealing with Prostate cancer as the symptoms of do not usually show themselves in the very early stages of the disease. The symptoms of PC are different for every man, and sometimes these early symptoms may be caused by some other conditions. It’s estimated that less than 5% percent of patients with prostate cancer show early warning symptoms in standard urine tests. For this reason, routine screenings focus on early detection are very important. Prostate-specific androgen (PSA) and Digital rectal exams (DRE) and recommended for all men over 50 years old and possibly earlier if you have family history of the disease. The symptoms of Prostate cancer often mimic those or other issues, so a small percentage of patients are not diagnosed with prostate cancer until it has metastasized to other areas in the body.
Most urologists describe the spread and growth of prostate cancer in one of 4 stages. Urologists and treatment providers often use the stage of cancer as a guide when offering prognosis or choosing treatment options. The 4 stages of Prostate cancer are based on a variety of factors, including screening tests such as:
To determine the stage of prostate cancer, most urologists around the world start with the “TNM staging system” which helps define the different aspects of prostate cancer growth.
After a urologist calculates the TNM components, it will often be combined with the Gleason grading system to determine which stage of prostate cancer the patient is currently in. Prostate cancer survival rates are often based on the actual stage and timing of the diagnosis.[3]
Currently, the most widely used traditional treatment options for men with prostate cancer are:
For patients with slow-growing prostate cancers that are detected early, active surveillance is used to monitor the tumor for any significant (negative) signs. For others, prostate cancer surgeries are usually recommended. Some common laparoscopic or open surgeries include radical prostatectomy or salvage radical prostatectomy for recurrent cases and can be done by themselves or combined with other treatments such as radiation therapy (radiotherapy.)
Some common types of Radiotherapy include:
For patients with small, localized (non-metastasized) prostate tumors, non-invasive techniques like partial gland ablation, Cryotherapy, and focal therapy and Brachytherapy can be used to target small areas of the prostate, but the recurrence rates are quite high and may not be the ideal solution to get rid of cancer.
For patients with aggressive prostate cancers, combined treatments are often recommended that includes a mix of radiation, brachytherapy, hormone therapy or external-beam therapy to try to reduce the overall adverse effects of radiation exposure.
For high-risk patients or patient’s where cancer has spread outside the prostate, the traditional approach is to use chemotherapy, systemic therapies, hormonal therapy, biologics or bone-targeted therapy with mixed results.
The Side effects and risks of prostate surgery like radical prostatectomy can be high and in line with any major surgery. Problems and risks of surgery can include:
The significant side effects of having radical prostatectomy surgery include:
At the Regeneration Center, our team of experts seeks to provide a well-rounded integrative approach to the treatment of prostate cancer. Our goal is for Long-Term Remission of prostate cancer and Therapy-Resistant Cancers that traditional treatments are unable to solve.[4] Our safe and effective Biological treatment plans are individualized to the patients’ exact needs without the excessive risks or radiation or surgical treatment approaches. Our holistic approach is built on the power of functional medicine and combines research-based alternative medicines, regenerative medicine with conventional treatments for prostate cancer offering patients the optimal chances for success.
Our modern and non-toxic immunotherapy protocols such as Transurethral Prostate Hyperthermia (TUH) are specifically designed to help restore the body’s defense mechanisms the immune system only to recognize and destroy cancer cells. The patient’s immune cells are first collected in a process called leukapheresis then cultured with specific proteins that activate themselves after being reintroduced to the patient’s body and immune system.[5]
This targeted immunotherapy for cancer of the prostate has very little to no adverse effects and is often combined with other forms of modern Biological therapies such as:
The Regeneration Center Immunotherapy for cancer focuses on many factors including the tumor microenvironment as it possesses a pivotal role in the remission or progression of cancer. This integrative functional medical strategy has been proven to help improve overall outcomes many cancer types in all stages. Browse our website or contact one of our support team directly to learn more about our cancer immunotherapy protocols and how they can be used effectively to achieve long-term prostate cancer remission for years, possibly decades.
Our Prostate cancer treatment and research center continues to probe further than ever before. With new discoveries, clinical trials for prostate cancer and emerging methods of diagnosing using genetic screening before treating prostate cancers, we firmly believe that we are well on our way to manage an otherwise fatal to allow our patients to finally live a cancer-free life without constant fear of relapse.
To determine eligibility and get exact prices along with day by day treatment outline our oncologists will need to better understand the patient’s existing needs via recent histological results, Biopsies, blood tests, x-rays or radiology scans from your primary care urologist or oncologist.
If you or a loved one have been diagnosed with prostate cancer, be aware of alternative medical solutions to fight cancer using HSC+ modified immune cells. Take the first step toward treatment by allowing your care to be handled by our team of experts in our advanced facility. We are here to help. To learn more about the safe and effective alternative treatment for Prostate Cancer please contact us today.
[1] ^ Lojanapiwat, Bannakij, Choosak Pripatnanont, Vorapot Choonhaklai, Surithorn Soontornpun, Supon Sriplakich, Sunai Leewansangtong, Apirak Santi-Ngamkun, et al. 2017. Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand. Prostate international, no. 1 (January 11). doi:10.1016/j.prnil.2017.01.002. https://www.ncbi.nlm.nih.gov/pubmed/28352616
[2] ^ Janiczek, Marlena, Łukasz Szylberg, Anna Kasperska, Adam Kowalewski, Martyna Parol, Paulina Antosik, Barbara Radecka, and Andrzej Marszałek. 2017. Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review. Journal of immunology research (October 3). doi:10.1155/2017/4861570. https://www.ncbi.nlm.nih.gov/pubmed/29109964
[3] ^ Bilusic, Marijo, Ravi A Madan, and James L Gulley. 2017. Immunotherapy of Prostate Cancer: Facts and Hopes. Clinical cancer research : an official journal of the American Association for Cancer Research, no. 22 (June 29). doi:10.1158/1078-0432.CCR-17-0019. https://www.ncbi.nlm.nih.gov/pubmed/28663235
[4] ^ Lojanapiwat, Bannakij. 2015. Urologic cancer in Thailand. Japanese journal of clinical oncology, no. 11 (September 9). doi:10.1093/jjco/hyv125. https://www.ncbi.nlm.nih.gov/pubmed/26355159
[5] ^ Pizzola, Christopher, Syed M Rizvi, and Monika Joshi. 2016. A New Era of Immunotherapy in Prostate Cancer. Current molecular pharmacology, no. 3. https://www.ncbi.nlm.nih.gov/pubmed/26177645